Milipertine
A serotonin receptor antagonist
| Milipertine | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Milipertine is a chemical compound that acts as a serotonin receptor antagonist. It is primarily known for its effects on the central nervous system and has been studied for its potential therapeutic applications in various psychiatric disorders.
Pharmacology[edit | edit source]
Milipertine functions by blocking the action of serotonin at its receptor sites. This action is believed to modulate neurotransmission in the brain, which can influence mood and behavior. The compound has been investigated for its potential use in treating conditions such as depression, anxiety disorders, and other mood-related disorders.
Mechanism of Action[edit | edit source]
Milipertine primarily targets the 5-HT2A receptor, a subtype of serotonin receptor. By antagonizing this receptor, Milipertine can alter the downstream signaling pathways that are involved in mood regulation and perception. This mechanism is similar to that of other antipsychotic and antidepressant medications that also target serotonin receptors.
Clinical Applications[edit | edit source]
While Milipertine has shown promise in preclinical studies, its clinical applications are still under investigation. The compound's ability to modulate serotonin pathways suggests potential benefits in treating major depressive disorder and generalized anxiety disorder. However, further clinical trials are necessary to establish its efficacy and safety profile.
Side Effects[edit | edit source]
As with many serotonin receptor antagonists, Milipertine may cause side effects such as drowsiness, dry mouth, and gastrointestinal disturbances. The severity and occurrence of these side effects can vary depending on the dosage and individual patient factors.
Research and Development[edit | edit source]
Research into Milipertine is ongoing, with studies focusing on its pharmacokinetics, optimal dosing regimens, and long-term effects. The compound's potential to be used in combination with other psychotropic drugs is also being explored to enhance therapeutic outcomes.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
